Gastrointestinal side effectsnausea, vomiting, constipationoccur more frequently with tirzepatide because the dual-receptor activation intensifies gastric emptying delays
T.BaigF.BarberT
The people experiencing transformative outcomes are the ones whose obesity was being driven primarily by the mechanisms GLP-1 actually targets: inflammation, gut signaling, neurological dysregulation
Work performed in the German, French and Belgian laboratories was supported by grants from the German Federal Ministry of Education and Research (BMBF GANI-MED 03152061A and BMBF 0314107), European Union Framework Programme 7 (EPC-TM, REGPOT-2010-1 and BetaBat), Europische Fonds fr regionale Entwicklung, State Ministry of Economics Mecklenburg-Vorpommern (V-630-S-150-2012/132/133), Deutsche Forschungsgemeinschaft (RO 3929/1-1, RO 3939/2-1 1, Wi 2036/2-3, SFB 1052 C01 and SPP 1629 TO 718/2-1), Colora Stiftung gGmbH, Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitt Leipzig), INSERM, French Association des Pancratites Chroniques Hrditaires (APCH), Actions de Recherche Concerte de la Communaut Franaise (ARC) and Fonds National de la Recherche Scientifique (FNRS, Belgium)
Clinical trials show Wegovy produces significantly more weight loss-approximately 2.5x greater-than Trulicity
Disequilibrium of the airway reducing state is a determinant of asthma initiation and severity [1, 46]
